-
Likelihood of Approval and Phase Transition Success Rate Model - JNJ-18038683 in Bipolar Disorder (Manic Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-18038683 in Bipolar Disorder (Manic Depression) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-18038683 in Bipolar Disorder (Manic Depression) Drug Details: JNJ-18038683...
-
Likelihood of Approval and Phase Transition Success Rate Model - Prexasertib Mesylate Monohydrate in Refractory Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prexasertib Mesylate Monohydrate in Refractory Medulloblastoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prexasertib Mesylate Monohydrate in Refractory Medulloblastoma Drug Details: Prexasertib...
-
Likelihood of Approval and Phase Transition Success Rate Model - Sargramostim in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sargramostim in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Non-Small Cell Lung Cancer Drug Details: Sargramostim...
-
Likelihood of Approval and Phase Transition Success Rate Model - IRX-4204 in Parkinson's Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IRX-4204 in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IRX-4204 in Parkinson's Disease Drug Details: IRX-4204 (NRX-4204) is under development...
-
Likelihood of Approval and Phase Transition Success Rate Model - Dostarlimab in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dostarlimab in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dostarlimab in Soft Tissue Sarcoma Drug Details: Dostarlimab (Jemperli) is...
-
Likelihood of Approval and Phase Transition Success Rate Model - Opaganib in Coronavirus Disease 2019 (COVID-19) Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Opaganib in Coronavirus Disease 2019 (COVID-19) Pneumonia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Opaganib in Coronavirus Disease 2019 (COVID-19) Pneumonia Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Fadraciclib in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fadraciclib in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fadraciclib in Pancreatic Cancer Drug Details: Fadraciclib is under development for the...
-
Likelihood of Approval and Phase Transition Success Rate Model - Fasedienol in Social Anxiety Disorder (SAD/Social Phobia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fasedienol in Social Anxiety Disorder (SAD/Social Phobia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fasedienol in Social Anxiety Disorder (SAD/Social Phobia) Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Tolinapant in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tolinapant in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tolinapant...
-
Likelihood of Approval and Phase Transition Success Rate Model - Gammora in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gammora in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gammora in Coronavirus Disease 2019 (COVID-19) Drug Details: Gammora...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.